142 related articles for article (PubMed ID: 1372760)
1. Prognostic factors in metastatic disease.
Droz JP; Kramar A; Rey A
Semin Oncol; 1992 Apr; 19(2):181-9. PubMed ID: 1372760
[No Abstract] [Full Text] [Related]
2. Testicular cancer. Clinical practice guidelines in oncology.
Motzer RJ; Bolger GB; Boston B; Carducci MA; Fishman M; Hancock SL; Hauke RJ; Hudes GR; Jonasch E; Kantoff P; Kuzel TM; Lange PH; Levine EG; Logothetis C; Margolin KA; Pohar KS; Redman BG; Robertson CN; Samlowski WE; Sheinfeld J;
J Natl Compr Canc Netw; 2006 Nov; 4(10):1038-58. PubMed ID: 17112452
[No Abstract] [Full Text] [Related]
3. Serum lactate dehydrogenase isoenzyme 1 and tumour volume are indicators of response to treatment and predictors of prognosis in metastatic testicular germ cell tumours.
von Eyben FE; Blaabjerg O; Madsen EL; Petersen PH; Smith-Sivertsen C; Gullberg B
Eur J Cancer; 1992; 28(2-3):410-5. PubMed ID: 1375486
[TBL] [Abstract][Full Text] [Related]
4. Treatment options for stage I nonseminoma.
Feldman DR
J Clin Oncol; 2014 Dec; 32(34):3797-800. PubMed ID: 25366681
[No Abstract] [Full Text] [Related]
5. Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers alpha-fetoprotein and human chorionic gonadotropin.
Fottner C; Sattarova S; Hoffmann K; Spöttl G; Weber MM
Eur J Endocrinol; 2008 Sep; 159(3):317-27. PubMed ID: 18524796
[TBL] [Abstract][Full Text] [Related]
6. Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience.
Bosl GJ; Geller NL; Cirrincione C; Nisselbaum J; Vugrin D; Whitmore WF; Golbey RB
Am J Med; 1983 Jul; 75(1):29-35. PubMed ID: 6190398
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89.
Calaminus G; Schneider DT; Bökkerink JP; Gadner H; Harms D; Willers R; Göbel U
J Clin Oncol; 2003 Mar; 21(5):781-6. PubMed ID: 12610174
[TBL] [Abstract][Full Text] [Related]
8. [Value of tumor marker positivity in germinal non-seminomatous tumors of the testis].
Bassetto MA; Franceschi T; Lenotti M; Pancheri F; Zaninelli M; Corgnati A; Cetto GL
J Nucl Med Allied Sci; 1990; 34(4 Suppl):89-90. PubMed ID: 1709212
[No Abstract] [Full Text] [Related]
9. Nonseminomatous germ cell tumors of the testis: current concepts and controversies.
Sheinfeld J
Urology; 1994 Jul; 44(1):2-14. PubMed ID: 7518979
[No Abstract] [Full Text] [Related]
10. Germ cell tumours of testis: prognostic factors and results.
Nikzas D; Champion AE; Fox M
Eur Urol; 1990; 18(4):242-7. PubMed ID: 1705226
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease.
Gerl A; Clemm C; Lamerz R; Mann K; Wilmanns W
Eur J Cancer; 1993; 29A(7):961-5. PubMed ID: 7684597
[TBL] [Abstract][Full Text] [Related]
12. [Determination of specific markers in the blood in tumors of the testis].
Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK
Klin Khir (1962); 1990; (5):47-8. PubMed ID: 1697352
[No Abstract] [Full Text] [Related]
13. Clinical use of A.F.P. and H.C.G. in testicular tumours of germ-cell origin.
Lancet; 1978 Nov; 2(8098):1042. PubMed ID: 82048
[No Abstract] [Full Text] [Related]
14. Prognostic factors in nonseminomatous testicular cancer.
Javadpour N
Prog Clin Biol Res; 1985; 203():271-86. PubMed ID: 2421330
[No Abstract] [Full Text] [Related]
15. Testicular cancer: role of biological tumor markers.
Pearson JC; Spaulding JT; Friedman MA
Cancer Treat Rev; 1979 Dec; 6(4):217-21. PubMed ID: 93978
[No Abstract] [Full Text] [Related]
16. Testicular cancer: risk stratification in adolescents with nonseminoma.
Looijenga LH
Nat Rev Urol; 2014 Jul; 11(7):367-8. PubMed ID: 24960597
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and immunologic diagnosis of cancer. Germ cell tumors.
Schwartz MK
Tumour Biol; 1987; 8(2-3):106-8. PubMed ID: 2452467
[No Abstract] [Full Text] [Related]
18. Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.
Wood DP; Herr HW; Motzer RJ; Reuter V; Sogani PC; Morse MJ; Bosl GJ
Cancer; 1992 Nov; 70(9):2354-7. PubMed ID: 1382832
[TBL] [Abstract][Full Text] [Related]
19. Management of clinical stage I nonseminomatous germ cell testicular cancer.
Choueiri TK; Stephenson AJ; Gilligan T; Klein EA
Urol Clin North Am; 2007 May; 34(2):137-48; abstract viii. PubMed ID: 17484919
[TBL] [Abstract][Full Text] [Related]
20. Clinical analysis of management of pediatric testicular germ cell tumors.
Ye YL; Sun XZ; Zheng FF; Bian J; Huang YP; Zhang XQ; Li ZX; Nie Y; Qin ZK; Dai YP
Urology; 2012 Apr; 79(4):892-7. PubMed ID: 22305424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
